Nature One Dairy, a dairy firm based in Melbourne, Australia, has signed a strategic partnership with Chinese pharmacy giant Sinopharm to manufacture baby formula, specialised milk powder products and other health-related products to import to China.
China is reported to be introducing a new policy from January 2018 that will limit the number of infant formula brands that manufacturers can register in China.
The agreement is said to include a deal to “produce all-Australian made infant milk formula brand in its Australian manufacturing facility for Sinopharm for China”.
Nick Dimopoulos, CEO of Nature One Dairy, said: “Our aim is to be able to produce a wide range of formulated products to meet the demands of different consumer groups”. Sinopharm was chosen as a strategic partner due to “its pharmaceutical-grade manufacturing facility and stringent food safety and quality management program”, he added.
Source: Food & Beverage / Dairy Reporter